Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Clinical trial NCT06681012 · RECRUITING

Trial details

NCT number: NCT06681012
Sponsor: Devintec Sagl
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Start date: 2024-10-22
Primary completion: 2027-07-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.